2024 American Heart Association scientific statement on the diagnosis and management of cardiac sarcoidosis:core interpretations of multimodal imaging
SA Fen
KAISAIERJIANG Aisikaier
CHEN Xiuyu
ZHAO Shihua
Abstract：In 2024,the American Heart Association(AHA)issued a scientific statement on the diagnosis and management of cardiac sarcoidosis(CS),systematically outlining the diagnostic and therapeutic framework for this infiltrative cardiomyopathy characterized by non-necrotizing granulomatous inflammation.The Statement emphasizes that multimodal imaging is a core pillar of CS diagnosis.This article focuses on the core content of the statement,specifically interpreting the clinical application value and diagnostic standards of multimodal imaging techniques for CS,as well as the collaborative diagnostic and therapeutic strategies involving cardiac magnetic resonance(CMR)and positron emission tomography(PET),with the aim of providing precise imaging assessment pathways for clinical practice.
Keywords：Cardiac sarcoidosisCardiac magnetic resonancePositron emission tomographyMagnetic resonance imaging
Publication Date：2025-03-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 164-167 )